Skip to main content
Equibles

Caption Management, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,012,475
-$372,550 QoQ
Shares Held
75,277
-27.3% QoQ
Ownership
0.440%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#48
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Derivatives in RNA

reported options exposure · as of Jun 30, 2026
CallValue
$817,760
CallShares
60,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. RNA ranks #44 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in RNA

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $817,760 60,800
2026-06-30 $1,012,475 75,277
2026-03-31 $1,385,025 103,592
2026-03-31 $534,800 40,000
2026-03-31 $812,896 60,800